Enviva Partners (EVA) Reaffirms 2022 Guidance, Provides Q2 Operating and Financial Update
Go back to Enviva Partners (EVA) Reaffirms 2022 Guidance, Provides Q2 Operating and Financial Update| Teva Pharmaceutical Industries (NYSE: EVA) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $29.85 | |||
| Open | $0.42 | 52 Week Low | $13.40 | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $0.00 | |||
| Volume | 695,160 | |||||
